Clinical Trials Directory

Trials / Completed

CompletedNCT05016232

Adaptive Intervention to Facilitate PrEP Uptake/Adherence Among Transgender Women

Developing and Pilot Testing an Adaptive Intervention to Facilitate PrEP Uptake and Maximize PrEP Adherence Among At-Risk Transgender Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
123 (actual)
Sponsor
University of California, Los Angeles · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

"PrEP N' Shine" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Transgender women (TGW).

Detailed description

The "PrEP N' Shine" package includes two behavioral intervention components: 1. Peer-led, strengths-based case management (SBCM) for PrEP linkage and uptake, and 2. A resource-efficient, adaptive "stepped-care" technology and counseling intervention that addresses individualized barriers to optimal use. Stage 1: TGW will be equally randomized to receive either the strengths-based case management or standard of care referral to PrEP clinic. Stage 2: Those from stage 1 who initiate PrEP , regardless of stage 1 randomization condition, will then be equally randomized to either the "PrEP N' Shine" adherence intervention or standard of care comparison condition.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPrEP N' Shine: Strength Based Case Management (Stage 1)Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.
BEHAVIORALPrEP N' Shine: Stepped Adherence Training and Counseling (Stage 2)1. Initially TGW in this arm will receive daily 2-way gender-affirming text message reminders, and 2. Then those continuing to have poor adherence will receive the 4 (once per week for 3 to 4 weeks) more intensive counseling session with a clinical interventionist.

Timeline

Start date
2022-10-18
Primary completion
2024-05-31
Completion
2024-06-30
First posted
2021-08-23
Last updated
2024-07-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05016232. Inclusion in this directory is not an endorsement.